Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01565837
Title Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
Acronym SART
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wolfram Samlowski
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Comprehensive Cancer Centers of Nevada RECRUITING Las Vegas Nevada 89148 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field